Vaping, initially perceived as a safer alternative to smoking, is now linked to lung damage. Studies reveal that vaping ...

Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

The FDA has accepted for review the BLA for mepolizumab as an add-on maintenance treatment for eosinophilic COPD.

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

WESTFIELD - The adage of “don’t let limitations confine you” is one that Irene Lansing embodies on a daily basis.

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

Higher dietary magnesium intake is associated with a reduced risk of frailty in patients with chronic obstructive pulmonary ...

A dipstick urine test and a mobile app may help predict disease exacerbations in COPD patients as much as a week in advance, ...

GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval of a new indication for Nucala ...